SHIFT Newsroom · GLOBAL
GLP-1 prescribing patterns: research preprint
A preprint examines obesity and GLP-1 prescribing in a large integrated health system. It has not been peer reviewed.
This preprint examines clinical characteristics and prescribing patterns in a large integrated health system during the GLP-1 era.
It has not been peer reviewed. Findings from one health system cannot establish UK prescribing practice or a change to NHS access.
What this means in the UK
This research may have implications for the management of obesity in the UK, particularly in relation to GLP-1 therapies
Known facts
- A study has been published on obesity in the GLP-1 era, examining clinical characteristics and prescribing patterns in a large integrated health system